Kaiser doxyPEP study is promising against STIs like syphilis and chlamydia, but wasn't effective against gonorrhea.
A drug meant to prevent sexually transmitted infections if taken within 72 hours of unprotected sex appears to be working well against syphilis and chlamydia, but within a year of making the therapy widely available in California, it no longer protec... [5569 chars]